{"id":"W4318926335","doi":"10.1158/1078-0432.ccr-22-1989","title":"Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"Genentech; F. Hoffmann-La Roche","keywords":"Trastuzumab; Breast cancer; Medicine; Oncology; Adjuvant; Biomarker; Internal medicine; Adjuvant therapy; Neoadjuvant therapy; Cancer; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004258445,0.0004839242,0.00127829,0.0001800568,0.0002089371,0.0007909121,0.0005887645,0.0006125362,0.001203794],"category_scores_gemma":[0.002733581,0.0002621933,0.001034777,0.0003251577,0.0004034308,0.0004526145,0.0003744565,0.0007907452,0.0002666507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006178716,"about_ca_system_score_gemma":0.0007196969,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001147605,"about_ca_topic_score_gemma":0.002675836,"domain_scores_codex":[0.9986833,0.0008406936,0.00006707348,0.0001744677,0.0001569045,0.00007767529],"domain_scores_gemma":[0.9979253,0.0007263502,0.0005751821,0.0002365246,0.0001226367,0.0004140045],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7464586,0.004594681,0.1734834,0.0007426774,0.01400824,0.0001474014,0.0002572229,0.001627277,0.01377589,0.0001537728,0.002298238,0.04245256],"study_design_scores_gemma":[0.16419,0.1370779,0.6750126,0.0001119309,0.009579664,0.0004495552,0.000157453,0.001437994,0.005042609,0.0002285416,0.006639872,0.00007179573],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963414,0.001587549,0.0001656396,0.0001432773,0.00002035363,0.0001374291,0.001140224,0.00000951672,0.0004545144],"genre_scores_gemma":[0.9933914,0.000657197,0.0004544954,0.000305704,0.00003328555,0.0002508356,0.003983785,0.000008896191,0.0009144901],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004258445,"threshold_uncertainty_score":0.02252102,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5670680553339,"score_gpt":0.6237006534623429,"score_spread":0.0566325981284429,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}